MEN1 was originally identified as a tumour suppressor, and mutations of the MEN1 in humans have been associated with various endocrine tumours, including parathyroid hyperplasia, pituitary adenomas and islet cell tumours.11, 12. Here, MEN1 is linked to parathyroid hyperplasia.